Arvinas Competitors and Similar CompaniesClear all
Foghorn Therapeutics's competitors and similar companies include NextCure and Stelexis Therapeutics.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. | ||
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations Beltsville, US HQ | Locations New York, US HQ |
Employees | Employees 1123% decrease | Employees N/A | Employees 3 |
Valuation ($) | Valuation ($) 452 m | Valuation ($) 39.2 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($74.4m) (FY, 2025) | Net income ($55.8m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 50m | Total funding raised $ 160m | Total funding raised $ 43m |
For sources of this data, please see the company profile
View Company Profiles
NextCure
HQ
Beltsville, US
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View company
Stelexis Therapeutics
HQ
New York, US
Employees
3
Stelexis Therapeutics is a cancer therapeutics company.
View company